Online Motor Control in People With Parkinson's Disease
1 other identifier
interventional
100
1 country
1
Brief Summary
This study aims to better understand how people with Parkinson's control reaching movements. Specifically, we are asking how these individuals respond to different environmental perturbations. Testing includes reaching movements made within a virtual reality set-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 12, 2018
CompletedFirst Submitted
Initial submission to the registry
October 23, 2020
CompletedFirst Posted
Study publicly available on registry
November 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2026
ExpectedNovember 5, 2020
October 1, 2020
6 years
October 23, 2020
October 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
End-point errors
Euclidean distance from target to final hand position (units: cm); measurement derived from position data sampled at 1000 Hz
during intervention
Reaction times
Time from visual target presentation to movement onset (units: ms); measurement derived from position data sampled at 1000 Hz
during intervention
Movement times
Time from movement onset to movement end (units: ms); measurement derived from position data sampled at 1000 Hz
during intervention
Study Arms (1)
Behavioral testing
EXPERIMENTALInterventions
Basic science study of control of reaching movements
Eligibility Criteria
You may qualify if:
- Age 18-85 years
- Able to perform reaching movements of \~20 cm (8 inches)
- MMSE score ≥ 26/30
- Willing and able to attend all testing sessions
- Diagnosis of idiopathic Parkinson's disease per self report
- Currently taking dopaminergic/dopamine agonist medication
You may not qualify if:
- Any chronic or recent upper extremity musculoskeletal conditions that affects reaching
- Any neurological disorders other than Parkinson's disease (e.g., seizure disorders, closed head injuries with loss of consciousness greater than 15 minutes, CNS neoplasm, history of stroke)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Delawarelead
- National Institutes of Health (NIH)collaborator
Study Sites (1)
University of Delaware
Newark, Delaware, 19713, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hyosub Kim, PhD
University of Delaware
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2020
First Posted
November 5, 2020
Study Start
December 12, 2018
Primary Completion
December 12, 2024
Study Completion (Estimated)
December 12, 2026
Last Updated
November 5, 2020
Record last verified: 2020-10